TP53 and cancer: These results suggest that some miRNAs exert their oncogenic activity by negatively regulating human TP53 gene expression, adversely regulating apoptosis, cell cycle arrest and senescence of cancer cells, thus they could be considered attractive targets for new drug therapies.